Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) EBT Margin (2016)

Historic EBT Margin for Tenax Therapeutics (TENX) over the last 4 years, with Q2 2013 value amounting to 7083.29%.

  • Tenax Therapeutics' EBT Margin fell 299312000.0% to 7083.29% in Q2 2013 from the same period last year, while for Dec 2015 it was 5718161.02%, marking a year-over-year change of. This contributed to the annual value of 76534.78% for FY2024, which is 441431200.0% up from last year.
  • According to the latest figures from Q2 2013, Tenax Therapeutics' EBT Margin is 7083.29%, which was down 299312000.0% from 1085.17% recorded in Q1 2013.
  • Tenax Therapeutics' 5-year EBT Margin high stood at 22847.91% for Q2 2012, and its period low was 250580.02% during Q3 2010.
  • Moreover, its 4-year median value for EBT Margin was 1204.36% (2012), whereas its average is 19372.42%.
  • Per our database at Business Quant, Tenax Therapeutics' EBT Margin surged by 2000000000bps in 2011 and then plummeted by -299312000bps in 2013.
  • Over the past 4 years, Tenax Therapeutics' EBT Margin (Quarter) stood at 7562.32% in 2010, then tumbled by -141bps to 3074.85% in 2011, then soared by 90bps to 301.12% in 2012, then crashed by -2252bps to 7083.29% in 2013.
  • Its EBT Margin was 7083.29% in Q2 2013, compared to 1085.17% in Q1 2013 and 301.12% in Q4 2012.